Trials / Unknown
UnknownNCT02677467
Correlation Between Epistaxis and Cardiovascular Disease
Epistaxis Correlate With Cardiovascular Disease?
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Hanyang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Investigators examine blood-pressure variance, several cardiovascular risk factors of patient with epistaxis. As a result of collected data, investigators look into correlation between epistaxis and hypertensive cardiovascular disorder.
Detailed description
This study is prospective observational single blinded study. A participant is visit in the ER who patient with epistaxis. Investigators will enroll 50 patients with epistaxis. Exclusion criteria is that patient needs immediately treatment for hypertensive urgency or patient with nasal trauma. Investigators examine blood-pressure (BP) at five times in Emergency Department (ED) and out-patient department (opd) of Otorhinolaryngology (OL) . Investigators explain this study and ask to write consent for participant. After proper management of epistaxis, investigators get blood sampling of the participant and, the participant has a reservation to "opd of cardiovascular division of Internal Medicine" (CV opd) in the hospital. When the participant visit CV opd, the participant undergo 24-hours-BP-monitoring and Pulse wave velocity (PWV). After that, the participant will be follow-up for 3 months. Investigators collect 50 data from 50 participants as a registry and analyze the data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood-pressure variability | Day to Night Blood pressure variability |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-06-01
- Completion
- 2016-08-01
- First posted
- 2016-02-09
- Last updated
- 2016-02-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02677467. Inclusion in this directory is not an endorsement.